No Data
Buyback gathering on November 28th | tencent, aia insurance, etc. have all repurchased, with tencent spending 0.7 billion Hong Kong dollars.
According to the disclosure on November 29 by hkex, tencent bought back 1.75 million ordinary shares on November 28, involving 0.7 billion Hong Kong dollars, with a repurchase price ranging from 403.8 Hong Kong dollars to 397.6 Hong Kong dollars per share. Since the repurchase authorization resolution, the cumulative number of repurchased securities is 0.195 billion shares, accounting for 2.072% of the number of shares issued when the ordinary resolution was passed. aia bought back shares on 11
Baheal Pharma-B (02142.HK) spent 0.071 million Hong Kong dollars to buy back 0.06 million shares on November 28th.
On November 28, Herbet Pharmaceuticals-B (02142.HK) announced that on November 28, 2024, it will spend 0.071 million Hong Kong dollars to repurchase 0.06 million shares, with a repurchase price of 1.18-1.19 Hong Kong dollars per share.
This Thursday marks the start of the "soul negotiation" for medical insurance. Which companies are likely to be selected?
According to the National Medical Insurance Administration, a press conference will be held at 10 a.m. on November 28 at the National Medical Insurance Administration to announce the adjustments to the national medical insurance pharmaceutical catalog for 2024 and answer questions from reporters. This means that the results of the national negotiation for medical insurance centralized purchasing in 2024 will be announced this Thursday.
November 25th buyback collective | Tencent Holdings, AIA and others have successively repurchased, with Tencent Holdings spending 0.702 billion Hong Kong dollars.
According to the hkex disclosure on November 26, tencent (00700.HK), aia (01299.HK), and other companies repurchased shares. ① Tencent (00700.HK) repurchased 1.77 million shares of common stock on November 25, involving an amount of 0.702 billion Hong Kong dollars, with a repurchase price per share ranging from 402 Hong Kong dollars to 394 Hong Kong dollars. Since the repurchase authorization resolution, the total number of repurchased securities is 0.19 billion shares, accounting for 2.016% of the number of shares issued when the ordinary resolution was passed. ② AIA (01299.HK) on November 2
Huabo Pharmaceutical - B (02142.HK) spent 0.2404 million Hong Kong dollars to repurchase 0.2 million shares on November 25th.
Gelonghui, November 25th丨Hebei Medicine-B (02142.HK) announced that on November 25, 2024, it spent 0.2404 million HKD to repurchase 0.2 million shares, with the repurchase price ranging from 1.19 to 1.21 HKD per share.
Many innovative drugs stocks in Hong Kong suddenly soared!
On the morning of November 25, the hang seng index fell slightly, while the Hong Kong stock market's biomedical sector performed well. Notably, several biomedical companies saw their stock prices rise significantly due to recent news of major collaboration advancements.
No Data
